taurine has been researched along with Addiction, Opioid in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antalarmin did not produce a place preference or place aversion by itself in morphine-dependent rats." | 1.33 | Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. ( Cador, M; Koob, GF; Stinus, L; Zorrilla, EP, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mark, TL | 2 |
| Lubran, R | 1 |
| McCance-Katz, EF | 1 |
| Chalk, M | 1 |
| Richardson, J | 1 |
| Crits-Christoph, P | 1 |
| Markell, HM | 1 |
| Gibbons, MB | 1 |
| Gallop, R | 1 |
| Lundy, C | 1 |
| Stringer, M | 1 |
| Gastfriend, DR | 1 |
| Kassed, CA | 1 |
| Vandivort-Warren, R | 1 |
| Levit, KR | 1 |
| Kranzler, HR | 1 |
| Stinus, L | 1 |
| Cador, M | 1 |
| Zorrilla, EP | 1 |
| Koob, GF | 1 |
| Herzig, V | 1 |
| Schmidt, WJ | 1 |
| Litten, RZ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment for Alcohol Dependence With Gabapentin: A Double Blind Placebo Controlled Randomized Clinical Trial[NCT02771925] | Phase 4 | 25 participants (Actual) | Interventional | 2016-06-30 | Terminated (stopped due to Due to poor compliance of patients in the study.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for taurine and Addiction, Opioid
| Article | Year |
|---|---|
Medicaid coverage of medications to treat alcohol and opioid dependence.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Buprenorphine, Naloxone Drug Combination | 2015 |
A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol-Related Disorders; Delayed-Action Preparations; Fema | 2016 |
Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Delayed-Action Preparations; Disulfiram; | 2009 |
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Topics: Acamprosate; Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Avoidance Learni | 2005 |
Repeated-testing of place preference expression for evaluation of anti-craving-drug effects.
Topics: Acamprosate; Alcohol Deterrents; Analgesics, Opioid; Anesthetics, Local; Animals; Behavior, Animal; | 2005 |
International update: new findings on promising medications.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Clinical Trials as Topic; Cocaine; Comorbidity | 1996 |